The antineoplastic ifosfamide produces dose-dependent signs of neuroto
xicity. After ifosfamide overdose in a patient, we found excessive uri
nary excretion of glutaric acid and sarcosine, which is compatible wit
h glutaric aciduria type II, a defect in mitochondrial fatty acid oxid
ation that results from defective electron transfer to flavoproteins.
We therefore used the electron-accepting drug methylene-blue as an ant
idote for ifosfamide encephalopathy. In one patient, ifosfamide neurot
oxicity was rapidly reversed by methylene-blue 50 mg intravenously. In
another patient with previous episodes of ifosfamide encephalopathy,
methylene-blue was administered orally prophylactically. No symptoms o
f neurotoxicity were noted.